Stocks and Investing Stocks and Investing
Wed, October 6, 2021
[ 12:00 AM ] - WOPRAI
Todd Thomas Upgraded (VICI) to Buy and Held Target at $33 on, Oct 6th, 2021
[ 12:00 AM ] - WOPRAI
Sylvain Brunet Upgraded (VALE) to Hold on, Oct 6th, 2021
[ 12:00 AM ] - WOPRAI
Emily Chieng Maintained (STLD) at Strong Buy with Decreased Target to $72 on, Oct 6th, 2021
[ 12:00 AM ] - WOPRAI
Katy Huberty Downgraded (CDW) to Hold and Decreased Target to $196 on, Oct 6th, 2021
[ 12:00 AM ] - WOPRAI
Alton Stump Initiated (CCK) at Strong Buy and Held Target at $165 on, Oct 6th, 2021
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (TROW) at Hold with Decreased Target to $204 on, Oct 6th, 2021
[ 12:00 AM ] - WOPRAI
John Barnidge Initiated (TRUP) at Buy and Held Target at $110 on, Oct 6th, 2021
[ 12:00 AM ] - WOPRAI
Vince Valentini Upgraded (TRI) to Strong Buy on, Oct 6th, 2021
[ 12:00 AM ] - WOPRAI
Katy Huberty Downgraded (STX) to Hold and Decreased Target to $88 on, Oct 6th, 2021
[ 12:00 AM ] - WOPRAI
George Sutton Initiated (TACT) at Strong Buy and Held Target at $20 on, Oct 6th, 2021
Tue, October 5, 2021
[ 12:00 AM ] - WOPRAI
John Vinh Maintained (SYNA) at Buy with Increased Target to $230 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Andrew Nowinski Initiated (TENB) at Buy and Held Target at $60 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Colin Langan Maintained (TEN) at Buy with Decreased Target to $18 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Bill Carcache Downgraded (TFC) to Sell and Decreased Target to $64 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Tom Nikic Initiated (TDUP) at Buy and Held Target at $25 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Pavel Molchanov Maintained (TPIC) at Buy with Decreased Target to $44 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Michael Lonegan Upgraded (CWEN) to Buy and Increased Target to $36 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Benjamin Chaiken Maintained (CCL) at Buy with Increased Target to $41 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Michael Sison Maintained (CE) at Buy with Increased Target to $188 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Ananda Baruah Maintained (SNX) at Strong Buy with Increased Target to $165 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Pavel Molchanov Maintained (SOL) at Buy with Decreased Target to $13 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Ross Gilardi Maintained (URI) at Strong Buy with Increased Target to $440 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Colin Langan Maintained (VC) at Sell with Decreased Target to $88 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Tom Nikic Initiated (VFC) at Hold and Held Target at $72 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Andrew Nowinski Initiated (VRNS) at Hold and Held Target at $66 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Theresa Chen Maintained (VLO) at Buy with Increased Target to $82 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Michael Leithead Maintained (WLK) at Hold with Increased Target to $108 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Tom Nikic Initiated (UAA) at Buy and Held Target at $26 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
John Vinh Maintained (TXN) at Buy with Increased Target to $250 on, Oct 5th, 2021
[ 12:00 AM ] - WOPRAI
Matthew Harrison Downgraded (AVIR) to Hold and Held Target at $55 on, Oct 5th, 2021

Matthew Harrison Downgraded (AVIR) to Hold and Held Target at $55 on, Oct 5th, 2021


Published on 2024-10-27 18:03:52 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Downgraded "Atea Pharmaceuticals, Inc." (AVIR) to Hold and Held Target at $55 on, Oct 5th, 2021.

Matthew has made no other calls on AVIR in the last 4 months.



There is 1 other peer that has a rating on AVIR. Out of the 1 peers that are also analyzing AVIR, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew

  • Roanna Ruiz of "SVB Leerink" Initiated at Buy and Held Target at $60 on, Thursday, September 9th, 2021
Contributing Sources